Assessing the impact of a fistula after a pancreaticoduodenectomy using the Post‐operative Morbidity Index  by Miller, Benjamin C. et al.
ORIGINAL ARTICLE
Assessing the impact of a fistula after a pancreaticoduodenectomy
using the Post-operative Morbidity Index
Benjamin C. Miller1, John D. Christein2, Stephen W. Behrman3, Mark P. Callery4, Jeffrey A. Drebin1, Tara S. Kent4,
Wande B. Pratt4, Russell S. Lewis Jr1 & Charles M. Vollmer Jr1
1Departments of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 2Departments of Surgery, University of Alabama,
Birmingham Medical Center, Birmingham, AL, 3Departments of Surgery, University of Tennessee Health Sciences Center, Memphis, TN, and 4Departments
of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Abstract
Background: The Post-operative Morbidity Index (PMI) is a quantitative utility measure of a complication
burden created by severity weighting. The Fistula Risk Score (FRS) is a validated model that predicts
whether a patient will develop a post-operative pancreatic fistula (POPF). These novel tools might provide
further discrimination of the ISGPF grading system.
Methods: From 2001 to 2012, 1021 pancreaticoduodenectomies were performed at four institutions.
POPFs were categorized by ISGPF standards. PMI scores were calculated based on the Modified
Accordion Severity Grading System. FRS scores were assigned according to the relative influence of four
recognized factors for developing a clinically relevant POPF (CR-POPF).
Results: In total, 231 patients (22.6%) developed a POPF, of which 54.1% were CR-POPFs. The PMI
differed significantly between the ISGPF grades and patients with no or non-fistulous complications (P <
0.001). 64.9% of POPFs and 84.0% of CR-POPFs contributed the highest Accordion grade to the PMI.
Overall, the FRS correlated well with PMI (R2 = 0.81, P < 0.001).
Conclusion: These data quantitatively reinforce the ISGPF grades that were developed qualitatively
around the concept of clinical severity. CR-POPFs usually reflect the patient's highest Accordion score
whereas biochemical POPFs are often superseded. The correlation between FRS and PMI indicates that
risk factors for a fistula contribute to overall pancreaticoduodenectomy morbidity.
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Introduction
A post-operative pancreatic fistula (POPF) is considered one of
most foreboding complications after a pancreatic resection. This
morbid problem has previously been shown to contribute to the
developmentof other complications and significantmortality.1,2 To
develop a common system of classifying POPF, the International
Study Group on Pancreatic Fistula (ISGPF) designed a new and
universal set of standards to reconcile the myriad of preexisting
definitions.3,4 The result was a comprehensive description of a
pancreatic fistula and a system of grading for POPF based on
severity of the clinical impact on the patient. Predicated on evi-
dence of fluid containing elevated amylase activity, POPFs are
classified as grade A (least severe, biochemical fistulae) or grades B
and C, which have a greater clinical impact – also referred to as
clinically relevant post-operative pancreatic fistula (CR-POPF).
These grades have been qualitatively validated and generally glo-
bally accepted as proper nomenclature for POPF severity.5,6
However, like other post-operative complications to date, POPF
suffer from the inability to be compared quantitatively.
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The Post-operative Morbidity Index (PMI) is a measure of
complication burden.7 This system features utility weighting
scores which operate continuously from 0 to 1 to quantitatively
relate the clinical significance and duration of outcomes. A PMI
for post-operative complications is predicated upon the Modified
Accordion Severity Grading System, an extension of the T92 and
Clavien–Dindo scales which assess the clinical impact of a
patient’s post-operative course based on the therapeutics and
resources used tomanage it.8–11 The Accordion system assigns each
patient a grade from zero to six based on the severity of their
complication profile. Derived by expert opinion, each Accordion
grade has been assigned a numeric value (weight) that reflects its
relative burden on the utility scale. The aggregate of these values
determines the PMI for any given population studied (e.g. com-
plications, surgical procedures and institutions), which can then
be used in a comparative fashion. The first application of a PMI
utilized the rigorous standards of the ACS NSQIP database to
accrue complications.12 However, in theory the PMI can be
derived from any practice or institutional complication database.
The Fistula Risk Score (FRS) is a prospectively validated model
that strongly predicts whether a patient will develop a CR-POPF
after a pancreaticoduodenectomy (PD).13 This scale is based upon
four discrete risk factors for CR-POPF previously identified in the
context of the ISGPF framework.7,14,15 These variables include
small pancreatic duct size, soft gland texture, high-risk pathology
(any pathology exclusive of pancreatic cancer or chronic pancrea-
titis) and increased blood loss. The FRS is a 10-point scale that
relies on the relative influence of these four variables and has been
shown to effectively predict CR-POPF development and its seque-
lae.While pre-operative risk assessments for POPF rarely rule out
patients needing a resection, or reroute the course of post-
operative care, the FRS can be calculated at the point of pancreatic
anastomotic creation and therefore be utilized to tailor intra- and
post-operative management of this morbid complication.13–15
Both the ISGPF grading system and the FRS prediction tool
have been qualitatively validated but have yet to be scrutinized
quantitatively. Using the experience in PD at four high-volume
North American pancreatic specialty centres, the present study
aims to use the PMI as a tool to: (i) quantitatively determine the
soundness of the ISGPF framework of tiered severity; and (ii)
show the relationship between risk of CR-POPF (as determined
by the FRS) and its subsequent morbidity burden.
Methods
This study was approved by the Institutional Review Board (IRB)
at the Hospital of the University of Pennsylvania (HUP). Patients
were identified from four IRB-approved, prospectively accrued,
retrospectively reviewed pancreatic surgery databases from HUP,
Beth Israel Deaconess Medical Center (BIDMC) in Boston, the
University of Alabama at Birmingham (UAB) and the Baptist
Memorial Hospital, The University of Tennessee Health Science
Center, Memphis (UTHSC). Six pancreatic surgical specialists
performed pancreaticoduodenectomies with duct-to-mucosa
pancreatojejunostomy for all surgical indications between 2001
and 2012. Alternative methods of ductal management (i.e. pan-
creatogastrostomy; duct occlusion) were excluded.
Post-operative complications within 90 days were accrued for
each patient by clinical research associates according to definitions
set forth in our previous work.5,7 and were then graded according
to the six-point Modified Accordion Severity Grading System.10
Grades were assigned by, or under the supervision of, attending
surgeons with complication severity grading expertise. These
scores ranged from zero to six with a zero indicating no compli-
cations and a six indicating post-operative death directly as a
result of a complication of the resection (Table 1). Patients were
assigned a single Accordion grade even if they suffered numerous
complications. In such an event, only the complication type
leading to the patient’s overall highest Accordion grade was used
for calculations. Complications were separated into two categories
(pancreatic fistulous complications and non-fistulous complica-
tions) and analysed both together and separately.
Table 1 The Modified Accordion Grading System and associated severity weighting
Grade Description Severity
weight
0 No complications 0.000
1 Treatment of complication requires only minor invasive procedures that can be done at the bedside, such as
insertion of intravenous lines, urinary catheters, and nasogastric tubes, and drainage of wound infections.
Physiotherapy and antiemetics, antipyretics, analgesics, diuretics, electrolytes, and physiotherapy are permitted.
0.110
2 Complication requires pharmacologic treatment with drugs other than such allowed for minor complications, e.g.
antibiotics. Blood transfusions and total parenteral nutrition are also included.
0.260
3 No general anaesthesia is required to treat the complication: requires management by an
endoscopic,interventional procedure, or reoperation without general anaesthesia.
0.370
4 General anaesthesia is required to treat complication. Alternately, single-organ failure has developed. 0.600
5 General anaesthesia is required to treat complication and single organ failure has developed. Alternately,
multisystem organ failure (2 or more organ systems) has developed.
0.790
6 Post-operative death occurred. 1.000
Modified from Pembroke et al. JACS, 2010.
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When a complication was determined to be a POPF, it was
first categorized using the guidelines set forth by the ISGPF
based on the clinical effect of the POPF; they are grade A
(biochemical fistula), or grades B and C (CR-POPF).4 Each pre-
viously defined POPF was then assigned a POPF-specific Accor-
dion grade regardless of whether the POPF denoted the highest
grade complication for the patient or not. These particular
grades were derived using a logical matching process between
the ISGPF categorization standards and six levels of clinical
impact defined in the Accordion grading system. Using these cri-
teria there are only certain possibilities of Accordion levels for
each grade of POPF. Grade A POPFs can only be an Accordion
grade 0 or 1 (denoting operative drain presence at discharge);
grade B CR-POPFs are only comprised of Accordion grades 1
(prolonged drainage – in this case beyond three weeks), 2 (thera-
peutic medications applied) and 3 (usually percutaneous drain-
age); grade C CR-POPFs include only Accordion grades 4
(usually re-operations), 5 (usually multi-organ failure) and 6
(death from a fistula). It is important to note that while these are
the only possible grades directly as a result of a POPF, a patient
with a POPF may have a higher overall Accordion grade owing
to other, more severe complications. Thus, each patient who
manifests a POPF would have a POPF-specific grade as well as
an overall severity grade, which might be higher, lower, or
equivalent.
PMI scores reflect the average of the weighted Accordion
scores of any particular group and can possibly range from 0 to
1.00 continuously. These scores were calculated based on the pro-
tocol similar to that used to derive in the first descriptions of the
PMI.8–12,16 Under these guidelines each Accordion grade is granted
a specific quantified value (Table 1). These individual weighted
Accordion scores were then summed to create a total severity
burden score, and then divided by the number of patients to
calculate the aggregate PMI.
The risk factors for development of CR-POPF necessary to
determine the FRS (small duct size, soft pancreas texture, high-
risk pathology and increased blood loss) were accrued from the
individual databases of the four institutions as described by the
attending surgeon in their operative note. These were then
assigned discrete numerical values based on a predetermined
weighting system that is summarized in Table 2. FRS scores were
then tabulated by summing the numerical value contributed by
each individual risk factor and could range from zero (no risk) to
10 (maximum risk). FRS scores were then further grouped into
four possible risk zones for more practical utilization. These cat-
egories are Negligible Risk (0 points), Low Risk (1–2 points),
Moderate Risk (3–6 points) and High Risk (7–10 points).
Statistical analyses were performed using IBM SPSS, version
20 (SPSS Inc., Chicago, IL, USA). Qualitative and descriptive
statistics were tabulated and analysed to determine rates of com-
plications. Differences between ISPGF groups, FRS groups and
PMI were scrutinized using analysis of variance (anova) and
paired t-tests. All tests were considered significant at P < 0.05.
Results
In total, 1021 patients underwent a PD with P-J reconstruction at
four institutions (N = 444, 306, 136 and 135). Out of these
patients, 231 (22.6%) developed any sort of POPF (ISGPF grades
A, B or C); 125 (54.1%) of these were clinically relevant, equating
to 12.2% of the total cohort. A grade A (biochemical) fistula
occurred in 106 patients (10.4%), whereas 101 patients (9.8%)
developed a grade B fistula and 24 patients (2.4%) suffered a grade
C fistula. Beyond POPFs, 424 other patients (41.5%) developed a
complication which was not attributed to a pancreatic fistula and
367 patients (35.9%) incurred no complication of any kind. There
were 28 deaths in the series (2.7%), of which 7 were directly
attributable to a POPF (0.7%).Malignancy or chronic pancreatitis
was the indication for surgery in 54.6% of the patients.
As Table 3 illustrates, the PMI for the entire series of PDs was
0.211. By definition, the cohort of patients who developed no
complications has a PMI of 0.000. Overall, the PMI for the
patients who developed any sort of POPF was lower than the PMI
for the patients who developed a CR-POPF. The PMI value esca-
lated steadily across the progression of ISGPF grades up to a high
of 0.780 for the most severe Grade C fistulae. Patients who suf-
fered a complication exclusive of a fistula had an overall PMI
approximately equal to the overall PMI of POPF. The PMI differed
significantly between the individual ISGPF grades, A, B, and C,
and patients with no complications or non-fistulous complica-
tions (P < 0.001 for all comparisons; Fig. 1). Figure 2 illustrates
how patients who developed either a POPF, or any other compli-
cation, displayed unique spectrums of Accordion grades.
When looking specifically at the contribution of the fistula to
each ISGPF grade’s PMI, grade A fistulae had the lowest PMI on
Table 2 Fistula Risk Score for prediction of clinically-relevant pan-
creatic fistula (CR-POPF) after a pancreatoduodenectomy
Risk factor Parameter Points






















Total 0 to 10 points
From Callery et al. JACS, 2013.
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account of the fistula alone and the fistula provided the highest
Accordion value to the PMI less than half of the time (Table 3).
The PMI rose for the 101 patients with a grade B fistula, and was
the most severe complication by Accordion grade most of the
time. Grade C fistulae had the highest PMI and provided the
highest Accordion grade to the overall PMI of that particular
cohort every time. Overall, in 64.9% of POPFs the fistula
accounted for the patient’s highest Accordion grade to the PMI
calculation. However, this contribution rose to 84.0% when con-
sidering CR-POPFs exclusively.
Accordion grades (attributed specifically to fistula) distinctly
segregated for the various ISGPF grades. The 106 patients with a
Grade A POPF were composed nearly equally of Accordion 0 and
Accordion 1 severity grades. For patients who developed Grade B
POPFs, just 5.0% were Accordion 1 (representing the clinical sce-
nario of prolonged drainage beyond 3 weeks), whereas 40.6%
were Accordion 2. However, the majority reflected the need for a
non-operative intervention (Accordion 3). The composition of
Grade C fistulae was distributed equally between Accordion
classes 4, 5, and 6 indicating a reoperation, organ failure or death
occurred. In terms of pathology, high-risk pathology (anything
exclusive of pancreatic cancer and clinical pancreatitis) prevailed
both in POPFs overall and in CR-POPFs (65.4% and 72.8%,
respectively). The opposite is true in those whom had no compli-
cations or only non-fistulous complications; the majority of these
post-operative courses were in patients with pancreatic cancer or
clinical pancreatitis (both 60.4% of the time).
Overall, POPFs occurred 22.6% of the time and,when they were
the highestAccordion grade, they contributed 22.4%of the burden
to the PMI (severity weight: 48.06 out of 214.98 total). While the
frequency and burden of POPFs were almost identical, it is evident
that CR-POPFs contribute disproportionately to that overall sever-
ity burden of 22.4%.Grade A POPFs accounted for 46% of POPFs
by frequency but provided only 7% of the POPF burden. Analo-
gously, the 54% of POPFs that were clinically relevant provided
93% of the burden contributed by POPF (Fig. 3).A focused analy-
sis of the serious Accordion Grades 4, 5 and 6 complications shows
that for the overall series these occurred in 125 patients (12.2%).
The contribution of POPFs to these serious complications only
comes through ISGPF Grade C patients (N = 24) as there are no
Grade 4 or higher complications in patients with ISGPF A and B
POPFs. Therefore this 2.3% of patients in the overall series con-
tributed 19.2% of all the serious complications encountered.
There were 135 (13.2%) patients in the Negligible Risk group,
301 (29.5%) in the Low Risk group, 512 (50.1%) in the Moderate
Risk group and 73 (7.2%) in the High Risk group of the FRS.
Figure 4 shows that the FRS correlated well with the overall PMI
reflecting all complications encountered (R2 = 0.81, P < 0.001), as
well as the PMI only attributed to a fistula (R2 = 0.77, P < 0.001).
On the other hand, the FRS did not associate with the PMI of
non-fistulous complications (R2 = 0.4354, P = 0.045).
Discussion
Classification and management of post-operative complications
remains a challenge even with today’s more sophisticated









of fistula is highest
(POPF-specific PMI)
Contribution of fistulas to
highest severity score
N (% contribution)
No complications 367 (35.9) 0.00 NA NA
Non-fistulous Complications 424 (41.5) 0.323 NA NA
All POPFs 231 (22.6) 0.341 0.320 150 (64.9)
ISGPF Grade A 106 (10.4) 0.208 0.032 45 (42.5)
CR-POPF 125 (12.2) 0.453 0.357 105 (84.0)
ISGPF Grade B 101 (9.8) 0.375 0.257 81 (80.2)
ISGPF Grade C 24 (2.4) 0.780 0.780 24 (100)
All patients 1021 (100) 0.211 0.055 150 (14.7)
PMI, Post-operative Morbidity Index; POPF, post-operative pancreatic fistula; CR-POPF, clinically relevant ISGPF, International Study Group
Pancreatic Fistula; NA, not applicable.
Figure 1 Post-operative Morbidity Index (PMI) of fistula and non-
fistulous complications. The difference between all separate com-
parisons was significant at P < 0.001
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outcome reporting metrics. A clear advancement in complication
analysis occurred with the advent of qualitative severity grading
systems predicated on assessing the resources used to treat any
given adverse event.8–10,16,17 The concept of ‘burden’ has its basis in
the realization that a complication can manifest as a full spectrum
of clinical effects.11 Any particular occurrence of a given compli-
cation may not register the same effect on different patients. Even
in the face of a globally accepted, comprehensive, stratification
system such as the ISGPF guidelines, it is difficult to quantitatively
discern the difference in POPFs. This study attempts to address
this dilemma using the PMI, and is the first to apply such an
analysis to a specific surgical complication.
The PMI is a natural extension of the T92, Clavien–Dindo and
Accordion progression of complication severity grading.8–12
Although these scales accurately categorize complications into
severity strata, they fail to highlight the true impact imposed by
severe complications on the collective study population. The
original description of the PMI, based on data acquired from
ACS-NSQIP, was the first process to take these severity grades and
normalize them to accurately represent clinical burden of various
complications.11,12 A pancreatic fistula and its sequelae, however,
are not currently accrued by ACS-NSQIP. For this reason, the PMI
presented herein uses the previous work as a conceptual founda-
tion. Instead this study stems from comprehensive practice data-
bases accrued by pancreatic surgical specialists with familiarity
with severity grading.
This study demonstrates the capability to compare different
groups (in this case, grades of POPF) using severity weighted
utility scores. Severity weighting is important because it more
appropriately accounts for high grade complications that, while
they may be infrequent, add considerably to the overall clinical
burden (PMI). The use of the PMI as an index is also important.
No single patient has their own PMI rather they are assigned an
individual severity weight that reflects the complication with the
highest impact on them. The aggregate of each weighted Accor-
dion score across the particular population studied creates an









Figure 2 (a) Grade A fistula by Accordion grade. (b) Grade B fistula
by Accordion grade. (c) Grade C fistula by Accordion grade. (d)
Non-fistulous complications by Accordion grade. Overall frequency
of accordion grades by complication category
Figure 3 Post-operative pancreatic fistula (POPF) contribution to the
Post-operative Morbidity Index (PMI) and frequency
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different stocks. This collective indexing allows comparison not
between individual patients, but between whole cohorts, or
subsets, of patients. This study embodies the power of such an
index by better discerning the different grades of POPF defined by
the ISGPF.
The statistically significant difference between the PMIs of the
various ISGPF grades establishes quantitative levels for the clinical
burden of these fistulae. This serves to reinforce the grades that
were originally developed qualitatively around the concept of
clinical severity.4 To date, the ISGPF guidelines have been inde-
pendently validated by comparing them to outcome metrics such
as length of stay, readmission rates and costs.5,6 While the additive
burden of POPF may be intuitive, as in the original qualitative
segregation, this is the first time that it has been scrutinized by
quantitative assessment. ISGPF grades can be difficult to tease
apart; even the original classification document includes nuances
when appointing these grades.4 Furthermore, no study has been
able to accurately identify predictors which would discriminate
between the occurrence of Grade B compared with Grade C
CR-POPFs.13–15 If the ISGPF guidelines are to continue to be the
standard for fistula description, the discrimination between these
two groups of CR-POPF becomes increasingly relevant.
These data highlight how Accordion grades may be used to
assist a data abstractor in distinguishing between the various
types of this morbid problem. According to the ISGPF frame-
work, each grade of POPF appears to be associated with a char-
acteristic and finite set of Accordion grades. This means that even
if an abstractor is unclear about the ISGPF grade of a fistula based
on its clinical description, a distinction can easily be made based
on the Accordion grade associated with the fistulous aspects of
the complication.When the overall spectrum of Accordion grades
are assessed, grades for biochemical POPF look very similar to
those for patients who experienced only non-fistulous complica-
tions (Fig. 2a,d). This reinforces what is intuitively known; bio-
chemical fistulae are often superseded by other, more morbid,
complications.
However, this study also shows that although easily dismissed,
these ‘biochemical only’ Grade A POPFs are not as innocuous as
many surgeons believe, but actually do incur an element of burden
on patients. By definition an Accordion 0 is simply known as no
complication; however 42.9% of the grade A POPFs are graded as
Accordion level 0. In the case of fistulae this can actually occur
because of their ‘threshold’ definition as a biochemical increase in
drain amylase activity of at least 3¥ normal serum amylase levels.
Even if the labs indicate that a leak has developed, if the drain is
removed prior to discharge it has no clinical impact on the patient
and as such is graded as though no complication occurred at all
(Accordion 0). However, over half of the grade A POPFs were
graded as Accordion level 1, indicating the continuation of
operatively-placed drains upon discharge for elevated amylase
values in the post-operative period. These patients otherwise did
not demonstrate prolonged drainage (>3 weeks) that would raise
them into the Grade B category.4 This form of clinical manage-
ment increases the POPF-specific PMI for this group to 0.032, and
while very low, it is not zero. This indicates that biochemical
fistulae do sustain a certain clinical impact on the patient, as well
as a potential added cost with commonplace utilization of visiting
nurses in these scenarios.
The array of complications changes when looking at grade B
and C POPFs, which reside further up the Accordion scale both
when looking at fistulous complications only, and when other
complications are taken into account (Fig. 2b,c). This indicates
that when they develop, CR-POPFs are often the greatest con-













Figure 4 (a) Overall Post-operative Morbidity Index (PMI) compared
with the Fistula Risk Score FRS score. (b) Fistula attributed PMI
compared with the FRS score. (c) PMI of non-fistulous complica-
tions compared with the FRS score
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is particularly true of grade C POPFs which are equally distributed
between reoperation, organ failure and death. Although only
12.2% of patients developed a CR-POPF, these complications con-
tributed 20.8% to the overall burden used to calculate the PMI.
This means that in terms of frequency, CR-POPFs cause almost
twice the impact as would be thought simply by looking at their
occurrence. It is for this reason that prediction and management
of this particular entity is especially important in pancreatic resec-
tion surgery.
Figure 4 shows that the strong correlation between the Fistula
Risk Score and the overall PMI (as well as the fistula-specific
PMI) continues to substantiate this novel prediction tool. This
indicates that the four risk factors for CR-POPF that comprise the
FRS greatly contribute to overall burden of morbidity in PD. In
contrast, they do not seem to influence non-fistulous complica-
tions. The FRS was originally designed to predict the develop-
ment of CR-POPF.13 However, it is these particular fistulae that
drive the overall severity of a patient’s post-surgical recovery
course more than other complications, including biochemical
fistulae. In this way the FRS appropriately predicts not only
CR-POPF occurrence but, through it, overall morbidity in PD.
These variables can be recognized intra-operatively and, as such,
the FRS can help decision making at that important point of
impact and beyond.
This analysis is limited by the fact that the data were accrued
from individual practice databases that, although completed by
surgeons with proficiency in complication grading, lack the rigor
of the ACS-NSQIP methodology, as used in the original PMI
description.12 The advantages of ACS-NSQIP are that complica-
tions are gathered by trained reviewers and that each complication
is rigorously defined. This reduces variances among observers and
improves the quality of data going into an analysis. However, not
all practices or institutions, especially outside the United States,
partake in the ACS-NSQIP system. Furthermore, pancreas-
specific complications (e.g. POPF, delayed gastric emptying and a
post-pancreatectomy haemorrhage) are not currently accrued by
ACS-NSQIP, that is anticipated to change with the expected
implementation of HPB-NSQIP.18 It is very important to empha-
size that the methods used to obtain any given PMI need to be
explicitly described, so that comparisons between studies are
made on an equal footing. In other words, in order to compare
PMI amongst studies, it is necessary that complications are iden-
tified by similar processes so that the definitions of post-operative
complications are the same.
Conclusion
Quantification of complications allows for measurement of the
severity of the post-operative course, and furthermore facilitates
the ability to perform comparative studies in surgical outcomes.
In the present study, PMI is used to reinforce the ISGPF scheme
and quantitatively establish a clear clinical impact for each grade
of fistula. The study also shows that POPF can result in every
Accordion severity level from 0–6 and that ISGPF grades segregate
into discrete Accordion profiles. Clinically relevant fistulae usually
reflect the patient’s highest Accordion score, whereas biochemical
POPFs are often superseded by more severe complications. The
frequent occurrence of highest-burden CR-POPFs highlights this
morbid complication, and begs for a reliable predictive tool to
help alleviate their post-operative severity. The FRS provides such
a tool, which can not only forecast CR-POPF development, but
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